NPC2 and metabolic dysfunction-associated steatohepatitis: The treatment-induced PPARG down-regulation and LDLR up-regulation in addition to adverse inductions of TNF and COL1A1 after four weeks NPC2 treatment may explain the overall lack of improvement in NASH changes.